Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADEPT: Acamprosate for Alcohol Detoxification
NCT00855699Phase 4Completed
- Sponsor
- University of Bristol
- Start
- Nov 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acamprosate in alcohol withdrawal syndrome (AWS), sponsored by University of Bristol. Started Nov 2009; status: completed.
02
Drugs
acamprosate
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT00855699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855699.